These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Am J Cardiol; 2006 Aug 15; 98(4):520-4. PubMed ID: 16893709 [Abstract] [Full Text] [Related]
11. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation. Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L. J Cardiovasc Med (Hagerstown); 2009 Sep 15; 10(9):671-6. PubMed ID: 19444135 [Abstract] [Full Text] [Related]
12. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981 [Abstract] [Full Text] [Related]
13. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W, Stanek B. J Heart Lung Transplant; 1998 Apr 22; 17(4):356-62. PubMed ID: 9588580 [Abstract] [Full Text] [Related]
14. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. Berger R, Huelsmann M, Strecker K, Moertl D, Moser P, Bojic A, Pacher R. Eur J Clin Invest; 2005 Jan 22; 35(1):24-31. PubMed ID: 15638816 [Abstract] [Full Text] [Related]
15. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression. Gwechenberger M, Pacher R, Berger R, Zorn G, Moser P, Stanek B, Huelsmann M. J Heart Lung Transplant; 2005 Dec 22; 24(12):2190-5. PubMed ID: 16364870 [Abstract] [Full Text] [Related]
16. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT. Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233 [Abstract] [Full Text] [Related]
17. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308 [Abstract] [Full Text] [Related]
18. Inflammatory mediators in Chinese patients with congestive heart failure. Wang Y, Zhou Y, Meng L, Lu X, Ou N, Li X. J Clin Pharmacol; 2009 May 15; 49(5):591-9. PubMed ID: 19398605 [Abstract] [Full Text] [Related]
19. [Comparative value of B-type natriuretic peptide and serum albumin concentration in the prediction of in-hospital mortality in elderly patients admitted for acute severe heart failure]. Arques S, Pieri B, Biegle G, Roux E, Gelisse R, Jauffret B. Ann Cardiol Angeiol (Paris); 2009 Nov 15; 58(5):279-83. PubMed ID: 19819420 [Abstract] [Full Text] [Related]
20. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, Nakamura S, Abe K, Yamamuro M, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H. Circulation; 2004 Sep 14; 110(11):1387-91. PubMed ID: 15353502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]